Boston Public Library
Kirstein Business Library

Second Floor, McKim Building, Central Library, 617-859-2142

Category Archives: Kirstein Business Library

New Books at Kirstein

Posted on June 24th, 2014 by Betsey Lippmeier in Kirstein Business Library

More new books have arrived,

so please check them out.

Supplier Discovery with Thomas Register

Posted on June 19th, 2014 by Gregor Smart in Internet Resources, Kirstein Business Library


Looking for a way to find a manufacturer or distributor of any given product? is a free and convenient resource that offers listing information for over 700,000 commercial and industrial suppliers.

Screening Options:

  • Search by Product/Service Category, Company Name, or Brand Name
  • Add Supplier Qualifications such as Manufacturer or Distributor
  • Add Geographic Location Information
  • Add Minority Ownership or Woman Ownership if desired

Read more »

New Books at Kirstein

Posted on June 12th, 2014 by Betsey Lippmeier in Kirstein Business Library

The new books keep coming in,

so please check them out.

SBA Business Plans

Posted on June 7th, 2014 by Gregor Smart in Kirstein Business Library


Are you looking to start a business and in need of a business plan?  Try the Small Business Administration’s Build Your Business Plan wizard.  Once you’ve completed the free registration, you’ll be guided through every step of the business plan building process. Completed plans can be downloaded into pdf format.

In depth assistance with each section of the business plan:

  • Cover Page
  • Executive Summary
  • Company Description
  • Market Research
  • Product/Service Line
  • Marketing & Sales
  • Financial Projections

  redcheckFor additional content check out the SBA’s: Small Business Learning Center  for access to online training cources and videos.

Food and Drug Administration Approves Biogen Idec Hemophilia Drug

Posted on June 7th, 2014 by Betsey Lippmeier in Kirstein Business Library

biogen idecTwo months after the Food and Drug Administration approved the first new hemophilia treatment in 17 years, its maker, Biogen Idec Inc., got approval on June 6 to market a drug that controls and prevents bleeding in adults and children with the most common form of the disease, hemophilia A.

An estimated 16,000 people in the United States have hemophilia A. This inherited disorder prevents normal blood clotting in patients, leading to repeated and extended bleeding that can cause pain and joint damage. Read more »